123 related articles for article (PubMed ID: 15708634)
1. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.
Julander JG; Winger QA; Olsen AL; Day CW; Sidwell RW; Morrey JD
Antiviral Res; 2005 Feb; 65(2):79-85. PubMed ID: 15708634
[TBL] [Abstract][Full Text] [Related]
2. West Nile virus infection of the placenta.
Julander JG; Winger QA; Rickords LF; Shi PY; Tilgner M; Binduga-Gajewska I; Sidwell RW; Morrey JD
Virology; 2006 Mar; 347(1):175-82. PubMed ID: 16406457
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine West Nile virus infection--New York, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Dec; 51(50):1135-6. PubMed ID: 12537289
[TBL] [Abstract][Full Text] [Related]
4. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.
O'Leary DR; Kuhn S; Kniss KL; Hinckley AF; Rasmussen SA; Pape WJ; Kightlinger LK; Beecham BD; Miller TK; Neitzel DF; Michaels SR; Campbell GL; Lanciotti RS; Hayes EB
Pediatrics; 2006 Mar; 117(3):e537-45. PubMed ID: 16510632
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004.
Paisley JE; Hinckley AF; O'Leary DR; Kramer WC; Lanciotti RS; Campbell GL; Hayes EB
Pediatrics; 2006 Mar; 117(3):814-20. PubMed ID: 16510662
[TBL] [Abstract][Full Text] [Related]
6. West Nile virus (WNV) transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion.
Blázquez AB; Sáiz JC
Virus Res; 2010 Aug; 151(2):240-3. PubMed ID: 20438776
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
Rios M; Daniel S; Dayton AI; Wood O; Hewlett IK; Epstein JS; Caglioti S; Stramer SL
J Infect Dis; 2008 Nov; 198(9):1300-8. PubMed ID: 18771407
[TBL] [Abstract][Full Text] [Related]
8. West Nile virus neutralization by US plasma-derived immunoglobulin products.
Planitzer CB; Modrof J; Kreil TR
J Infect Dis; 2007 Aug; 196(3):435-40. PubMed ID: 17597458
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
[TBL] [Abstract][Full Text] [Related]
10. [West Nile virus infection during pregnancy--a rare or an underreported disease?].
Rabinerson D; Glezerman M
Harefuah; 2009 Jan; 148(1):42-4, 87. PubMed ID: 19320389
[TBL] [Abstract][Full Text] [Related]
11. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.
Morelli MC; Sambri V; Grazi GL; Gaibani P; Pierro A; Cescon M; Ercolani G; Cavrini F; Rossini G; Capobianchi MR; Di Caro A; Menzo S; Pagliaro PP; Ghinelli F; Lazzarotto T; Landini MP; Pinna AD
Clin Infect Dis; 2010 Aug; 51(4):e34-7. PubMed ID: 20597692
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
Ben-Nathan D; Lustig S; Tam G; Robinzon S; Segal S; Rager-Zisman B
J Infect Dis; 2003 Jul; 188(1):5-12. PubMed ID: 12825165
[TBL] [Abstract][Full Text] [Related]
14. Transmission of West Nile virus through human breast milk seems to be rare.
Hinckley AF; O'Leary DR; Hayes EB
Pediatrics; 2007 Mar; 119(3):e666-71. PubMed ID: 17332186
[TBL] [Abstract][Full Text] [Related]
15. Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(39):877-8. PubMed ID: 12375687
[TBL] [Abstract][Full Text] [Related]
16. High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection.
Nielsen CF; Reisen WK; Armijos MV; Maclachlan NJ; Scott TW
Am J Trop Med Hyg; 2008 Jan; 78(1):45-52. PubMed ID: 18187784
[TBL] [Abstract][Full Text] [Related]
17. West Nile virus during pregnancy: a case study of early second trimester maternal infection.
Skupski DW; Eglinton GS; Fine AD; Hayes EB; O'Leary DR
Fetal Diagn Ther; 2006; 21(3):293-5. PubMed ID: 16601341
[TBL] [Abstract][Full Text] [Related]
18. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
20. Picornavirus infection in early murine gestation: significance of maternal illness.
Abzug MJ; Tyson RW
Placenta; 2000 Nov; 21(8):840-6. PubMed ID: 11095934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
